| Not Yet Recruiting | Minimally Invasive Prostate Interventions Registry (MIST Study) NCT07242807 | Necmettin Erbakan University | — |
| Not Yet Recruiting | TURP Outcome Prediction Calculator Study NCT07277556 | General Hospital Sveti Duh | — |
| Not Yet Recruiting | The FLOW Registry. NCT07430423 | University of Chicago | — |
| Recruiting | Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia NCT07016620 | The Cleveland Clinic | — |
| Not Yet Recruiting | Uroflowmetry Curve Types and IPSS in Men With LUTS NCT07016776 | Tarik Emre Sener | — |
| Recruiting | Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic NCT06769997 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Recruiting | Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging NCT06817733 | Chinese PLA General Hospital | N/A |
| Not Yet Recruiting | Desflurane Potentially Induces Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Perioperativ NCT06772558 | Xiaguang Duan | N/A |
| Recruiting | Effects of TNF Blockade on Human BPH/LUTS NCT06062875 | Endeavor Health | Phase 2 |
| Recruiting | The Evaluation of Banana Flower Stamens Extract on Prevention of Benign Prostatic Hyperplasia in Adults NCT04266418 | TCI Co., Ltd. | N/A |
| Completed | To Linguistically and Psychometrically Validate the Hong Kong Chinese Version of the BPH 3-item Questionnaire NCT05785286 | Chinese University of Hong Kong | — |
| Recruiting | Post-Market Study to Assess iTind Safety in Comparison to UroLift NCT04757116 | Olympus Corporation of the Americas | N/A |
| Active Not Recruiting | REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men NCT04838769 | Boston Scientific Corporation | N/A |
| Completed | HoLEP in Management of BPH Patients With Predominant Voiding vs Storage LUTS: A Comparative Retrospective Stud NCT04178811 | Assiut University | — |
| Completed | To Evaluate the Feasibility, Preliminary Safety and Performance of Rezūm System in BPH Treatment in China NCT04823221 | Boston Scientific Corporation | — |
| Unknown | Prostate Artery Embolization: Single Center Experience NCT04766268 | University of Mississippi Medical Center | N/A |
| Completed | Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overacti NCT04681625 | Comenius University | N/A |
| Recruiting | Aquablation vs. Holmium Laser Enucleation of the Prostate in the Treatment of Benign Prostatic Hyperplasia in NCT04560907 | Dr. med. Gautier Müllhaupt | N/A |
| Terminated | A Multi-center, International Prospective Follow up Study NCT04579913 | Medi-Tate Ltd. | — |
| Completed | A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. NCT04485585 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Unknown | Application of MOSES Technology in BPH NCT04648176 | Hospital Universitari Vall d'Hebron Research Institute | N/A |
| Withdrawn | Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer NCT03817216 | Case Comprehensive Cancer Center | N/A |
| Completed | Evaluate the Efficacy and Safety of GV1001 in Patients With Benign Prostatic Hyperplasia (BPH) NCT04032067 | GemVax & Kael | Phase 3 |
| Unknown | Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques NCT03846700 | University of Bari | N/A |
| Completed | China Greenlight Registry Study (Post-market) NCT03736512 | Boston Scientific Corporation | — |
| Completed | French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate NCT03191734 | PROCEPT BioRobotics | N/A |
| Completed | Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) NCT03052049 | Northwestern University | N/A |
| Completed | Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II NCT03123250 | PROCEPT BioRobotics | N/A |
| Unknown | Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia NCT03239652 | National Cheng-Kung University Hospital | N/A |
| Completed | Study of Median Lobe Prostatic UroLift Procedure NCT02625545 | NeoTract, Inc. | N/A |
| Unknown | Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia NCT02592473 | University of Virginia | N/A |
| Completed | Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) NCT02505919 | PROCEPT BioRobotics | N/A |
| Completed | A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH NCT02855892 | GemVax & Kael | Phase 2 |
| Completed | Benign Prostatic Hyperplasia and Ischemic Heart DIsease NCT03856242 | I.M. Sechenov First Moscow State Medical University | Phase 4 |
| Completed | Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of t NCT03460873 | Samsung Medical Center | — |
| Completed | Study to Assess the Efficacy of Medi-Tate iTind Device NCT02145208 | Medi-Tate Ltd. | N/A |
| Completed | A Prospective Investigation Using the Expired Breath Ethanol Test NCT02304549 | Daniel Stephan Engeler | — |
| Completed | PERmixon® in LUTS Evaluation Study (PERLES) NCT02121613 | Pierre Fabre Medicament | Phase 4 |
| Completed | Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH) NCT02026908 | Northwestern University | N/A |
| Terminated | Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US) NCT01896973 | HistoSonics, Inc. | N/A |
| Withdrawn | Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada) NCT01775488 | HistoSonics, Inc. | N/A |
| Completed | Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Vers NCT01604811 | Pierre Fabre Medicament | Phase 4 |
| Completed | PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination NCT01829893 | Korea University Anam Hospital | Phase 1 |
| Completed | Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic NCT01500057 | Brooklyn Urology Research Group | Phase 4 |
| Completed | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyp NCT01218243 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Phase 2 |
| Completed | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia NCT00970632 | Eli Lilly and Company | Phase 3 |
| Completed | Intraprostatic Botulinum Toxin Type "A" Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfac NCT01566292 | Catholic University of the Sacred Heart | Phase 2 / Phase 3 |
| Completed | Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) NCT00939120 | Siami, Paul F., M.D. | Phase 4 |
| Completed | Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 NCT00945490 | Nymox Corporation | Phase 3 |
| Terminated | Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH) NCT00743184 | Spectrum Pharmaceuticals, Inc | Phase 2 |
| Completed | A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy NCT00700505 | ThermaRx, Inc. | N/A |
| Terminated | A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Com NCT00651807 | Organon and Co | Phase 2 |
| Completed | Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for NCT02715024 | Astellas Pharma Taiwan, Inc. | Phase 4 |
| Completed | Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) NCT00759135 | Nymox Corporation | Phase 2 |
| Completed | A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo NCT00224107 | Watson Pharmaceuticals | Phase 3 |
| Completed | A Comparative Study of KSO-0400 in BPH Patients With LUTS NCT01222650 | Kissei Pharmaceutical Co., Ltd. | Phase 2 |